Coral Laboratories Limited (BOM:524506)

India flag India · Delayed Price · Currency is INR
440.75
+8.20 (1.90%)
At close: Mar 9, 2026
-43.64%
Market Cap 1.57B
Revenue (ttm) 875.55M
Net Income (ttm) 139.84M
Shares Out 3.57M
EPS (ttm) 39.14
PE Ratio 11.26
Forward PE n/a
Dividend 1.50 (0.35%)
Ex-Dividend Date Sep 19, 2025
Volume 2,948
Average Volume 1,390
Open 431.95
Previous Close 432.55
Day's Range 422.15 - 450.00
52-Week Range 415.00 - 788.00
Beta 0.84
RSI 49.84
Earnings Date Feb 13, 2026

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, ora... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 197
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524506
Full Company Profile

Financial Performance

In fiscal year 2025, Coral Laboratories's revenue was 1.15 billion, an increase of 37.47% compared to the previous year's 836.60 million. Earnings were 241.56 million, an increase of 52.99%.

Financial Statements

News

There is no news available yet.